Results 291 to 300 of about 749,314 (382)

Delivery of Natural Small Molecules Through Nanocarriers for Cancer Treatment

Food Frontiers, EarlyView.
Natural small molecules through nanocarriers for cancer treatment ABSTRACT Cancer is a formidable adversary, accounting for the second highest number of fatalities worldwide. A multitude of studies have indicated that naturally sourced small‐molecule compounds, owing to their low toxicity and multi‐target capabilities, significantly aid in the fight ...
Fangting Ye, Shaojie Zheng, Shuo Shan, Jiaer Cai, Yufan Liu, Weichao Chen, Xinxin He, Chao Zhao   +7 more
wiley   +1 more source

Gilteritinib-induced pyoderma gangrenosum in a patient with acute myeloid leukemia: A case report. [PDF]

JAAD Case Rep
Sisley J, deCampos-Stairiker M, Becker SL, Throckmorton SK, Swords R, Ortega-Loayza AG.   +5 more
europepmc   +1 more source

Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia.

Cancer Cell, 2019
Yue Huang, R. Su, Yue Sheng, Lei Dong, Ze Dong, Hongjiao Xu, Tengfeng Ni, Zijie Zhang, Tao Zhang, Chenying Li, Li Han, Zhenyun Zhu, F. Lian, Jiangbo W, Qiang-qiang Deng, Yungui Wang, M. Wunderlich, Zhi-wei Gao, Guoyu Pan, D. Zhong, Hu Zhou, Naixia Zhang, J. Gan, Hualiang Jiang, J. Mulloy, Zhijian Qian, Jianjun Chen, Cai-Guang Yang   +27 more
semanticscholar   +1 more source

Targeting PR1 in myeloid leukemia

Oncotarget, 2017
Gheath Alatrash, Muzaffar H. Qazilbash, Jeffrey J. Molldrem   +2 more
openaire   +3 more sources

Acute myeloid leukemia management and research in 2025. [PDF]

CA Cancer J Clin
Kantarjian HM, DiNardo CD, Kadia TM, Daver NG, Altman JK, Stein EM, Jabbour E, Schiffer CA, Lang A, Ravandi F.   +9 more
europepmc   +1 more source

Acute Myeloid Leukemia as a Trigger for Hemolytic-Uremic Syndrome. [PDF]

J Clin Med
El Bachouti J, Domínguez-Guasch A, Arce Y, Oñate G, Marco H, Diaz M, Guirado L, Torra R, Barros X.   +8 more
europepmc   +1 more source

On TRacK With Larotrectinib in a Neonate With a Giant Congenital ETV6::NTRK3 Fusion‐Positive Infantile Fibrosarcoma of the Head and Neck

Head &Neck, EarlyView.
ABSTRACT Background Infantile fibrosarcoma (IFS) is a rare pediatric tumor of intermediate malignancy with high local aggressiveness that typically presents in young infants. Its occurrence in the head and neck region is rare. Complete non‐mutilating surgical resection is often not possible, requiring multimodal treatment.
Teresa M. Cardesa‐Salzmann, Monika Sparber‐Sauer, Peter Hingst, Andreas Erbersdobler, Bjoern Schneider, Maja Hühns, Andre Jakob, Friederike Terpe, Christian Spang, Dorothea Stalmann, Claudia Bierwirth, Christina Hauenstein, Stefanie Märzheuser, Manfred Ballmann, Carl Friedrich Classen   +14 more
wiley   +1 more source

Inducing apoptosis in acute myeloid leukemia; mechanisms and limitations. [PDF]

Heliyon
Koolivand Z, Bahreini F, Rayzan E, Rezaei N.   +3 more
europepmc   +1 more source

Effects of vitamin D3 and IFN-gamma on the synthesis of the second complement component, C2, by a human myeloid leukemia (HL-60) cell line.

, 1988
Bruce H. Littman, Kerrie M. Sanders
openalex   +1 more source